Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States

@article{Patel2001IncreasingIA,
  title={Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States},
  author={Tushar Patel},
  journal={Hepatology},
  year={2001},
  volume={33}
}
  • T. Patel
  • Published 2001
  • Medicine
  • Hepatology
Clinical observations suggest a recent increase in intrahepatic biliary tract malignancies. Thus, our aim was to determine recent trends in the epidemiology of intrahepatic cholangiocarcinoma in the United States. Reported data from the Surveillance, Epidemiology, and End Results (SEER) program and the United States Vital Statistics databases were analyzed to determine the incidence, mortality, and survival rates of primary intrahepatic cholangiocarcinoma. Between 1973 and 1997, the incidence… Expand
Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002.
TLDR
The Danish incidence rates of intra- and extrahepatic cholangiocarcinomas were nearly identical throughout the study period, and the decreasing incidence rates cannot be explained by time trends in known risk factors. Expand
Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?
TLDR
The stable proportions over time of patients with early stage disease, unstaged disease, tumor size <5 cm, and microscopic confirmation suggest a true increase of ICC in the USA. Expand
Changing pattern of epidemiology in intrahepatic cholangiocarcinoma
TLDR
It is hypothesized that increased awareness of this disease and advances in imaging/surgical technology may have improved survival of patients with ICC and if these survival benefits are large enough, they should be detectable in a temporal trend analysis of ICC incidence and mortality. Expand
Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study.
TLDR
It is shown that in addition to previously well described risk factors, several others could be associated with intrahepatic cholangiocarcinoma, including hepatitis C virus, human immunodeficiency virus, liver cirrhosis, and diabetes. Expand
Racial, Ethnic, and Age Disparities in Incidence and Survival of Intrahepatic Cholangiocarcinoma in the United States; 1995-2014.
INTRODUCTION AND AIM Despite reports of increased incidence of intrahepatic cholangiocarcinoma (iCCA) in the United States, the impact of age or influences of race and ethnicity are not clear.Expand
A Comparison of Trends in the Incidence of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in the United States
TLDR
Trends by age, gender, ethnicity, and birth cohort suggest that heterogeneity exists in the factors influencing these rates of liver cancers, and approximately doubled between 1976 and 2000. Expand
Racial, Ethnic, and Age Disparities in Incidence and Survival of Intrahepatic Cholangiocarcinoma in the United States; 1995-2014.
INTRODUCTION Despite reports of increased incidence of intrahepatic cholangiocarcinoma (iCCA) in the United States, the impact of age or influences of race and ethnicity are not clear. Disparities inExpand
Worldwide trends in mortality from biliary tract malignancies
TLDR
There has been a marked global increase in mortality from intrahepatic, but not extra-hePatic, biliary tract malignancies, which was observed in all geographic regions. Expand
Intrahepatic cholangiocarcinoma in a low endemic area: rising incidence and improved survival.
TLDR
Between 1999 and 2009, the incidence of ICC rose, especially in the age group 45-59 years, suggesting aetiological influences, and survival rates have improved during the study period. Expand
Increasing mortality in the United States from cholangiocarcinoma: an analysis of the National Center for Health Statistics Database
TLDR
Based on the most recent national data, CCA mortality rates have increased substantially in the past decade and among different race/ethnic groups, African Americans have the highest increase in CCA deaths. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 20 REFERENCES
Rising incidence of hepatocellular carcinoma in the United States.
TLDR
The incidence of hepatocellular carcinoma increased significantly among younger persons (40 to 60 years old) during the period from 1991 to 1995 as compared with earlier periods, and the age-specific incidence of this cancer has progressively shifted toward younger people. Expand
Descriptive epidemiology of subsites of cancers of the liver, biliary tract and pancreas in Japan.
TLDR
The CAAMR for primary liver cancer was high in the Island of Kyushu and some western parts of Japan, and low in the northern part of Honshu Island, and no clear clusters of prefectures with high CAAMRs were observed for cancers of the intrahepatic bile duct and pancreas, other than for the pancreatic head. Expand
A clinical study of 130 patients with biliary tract cancers and periampullary tumors.
TLDR
Biliary cancers in Taiwan were not related to liver fluke infestation, inflammatory bowel disease or hepatitis B virus infection, but a close association with biliary lithiasis was found and overall survival was poor except in patients whose tumor could be completely resected. Expand
Risk of liver and other types of cancer in patients with cirrhosis: A nationwide cohort study in Denmark
TLDR
Evidence is found of an increased risk for liver and several extrahepatic cancers in patients with cirrhosis, which opens up the possibility that Cirrhosis plays a role in the carcinogenesis of types of cancer other than liver cancer. Expand
Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis.
TLDR
The measurement of serum concentrations of CA 19-9 is a promising test for detecting cholangiocarcinoma in patients with PSC. Expand
Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.
TLDR
A combination of serum tumor markers will identify most occult tumors and will improve selection of appropriate cases for orthotopic liver transplantation. Expand
Imaging of intrahepatic cholangiocarcinoma: 1. Peripheral cholangiocarcinoma.
TLDR
The appearances of peripheral cholangiocarcinoma are reviewed and the various imaging techniques that can be used to evaluate this unusual tumor that is often resectable and potentially curable are discussed. Expand
A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis.
TLDR
The serum tumor markers CEA, CA 19-9, CA 50 and CA 242 are of limited value for the detection of CC in patients with PSC because of low specificity, however, no falsely increased values in Patients with hyperbilirubinemia are found. Expand
Etiology and natural history of primary sclerosing cholangitis.
TLDR
The development of a multivariate statistical survival model from long-term survival data from the Mayo Clinic and other centers has been a major step in identifying individual primary sclerosing cholangitis patients at low, moderate, and high risk of dying. Expand
Biliary tract cancers.
TLDR
In the United States, an estimated 20,000 new cases of liver and biliary tract cancer are diagnosed annually; about 5000 of these are gallbladder cancer, and between 2000 and 3000 are bile-duct cancers. Expand
...
1
2
...